×

PFIZER COO SAYS TREATMENT OPPORTUNITIES ALMOST DOUBLE IF XTANDI APPROVED FOR PATIENTS WITH NON-METASTATIC DISEASE

PFIZER COO SAYS TREATMENT OPPORTUNITIES ALMOST DOUBLE IF XTANDI APPROVED FOR PATIENTS WITH NON-METASTATIC DISEASE